For the quarter ended June 2026, Adient (ADNT Quick QuoteADNT - Free Report) reported revenue of $3.93 billion, up 5% over the same period last year. EPS came in at $0.48, compared to $0.45 in the year-ago quarter.

The reported revenue represents a surprise of +6.08% over the Zacks Consensus Estimate of $3.7 billion. With the consensus EPS estimate being $0.53, the EPS surprise was -9.43%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Adient performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net Sales- Americas: $1.93 billion compared to the $1.76 billion average estimate based on three analysts. The reported number represents a change of +9.6% year over year.
• Net Sales- Eliminations: $-20 million versus the three-analyst average estimate of $-23.31 million. The reported number represents a year-over-year change of +150%.
• Net Sales- Asia: $810 million versus $725.59 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +12.3% change.
• Net Sales- EMEA: $1.21 billion versus $1.22 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -4.5% change.

View all Key Company Metrics for Adient here>>>

Shares of Adient have returned +10.2% over the past month versus the Zacks S&P 500 composite's +3.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.